Margaret A. Alexander - 04 Jan 2026 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role: President and CEO, Director
Signature: /s/ Jeffrey Rona, Attorney-in-Fact
Issuer symbol: OVID
Transactions as of: 04 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 05 Jan 2026, 17:55:06 UTC
Previous filing: 28 Feb 2025
Next filing: 02 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
ALEXANDER MARGARET A.	President and CEO, Director	C/O OVID THERAPEUTICS INC., 441 NINTH AVENUE, 14TH FLOOR, NEW YORK	/s/ Jeffrey Rona, Attorney-in-Fact	05 Jan 2026	0002036798

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OVID	Employee Stock Option (right to buy)	Award	$0	+890,000		$0.000000	890,000	04 Jan 2026	Common Stock	890,000	$1.76	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the Stock Option will vest and become exercisable on January 1, 2027 and the remaining shares will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued services through such date.